COO (The Cooper) Other Stockholders Equity: $0 Mil (As of Apr. 2026)


COO The Cooper Companies Inc COO
89 GF Score
Price $70.74
GF Value $100.88
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is The Cooper Other Stockholders Equity?

The Cooper COO -0.39% 89 Other Stockholders Equity is $0 Mil as of Apr. 2026. GuruFocus rates COO with a GF Score™ of 89/100 and a GF Value™ of $100.88 (Significantly Undervalued). The stock has 3 warning signs investors should review.

The Cooper's Other Stockholders Equity for the quarter that ended in Apr. 2026 was $0 Mil.

The Cooper's annual Other Stockholders Equity declined from Oct. 2023 ($0 Mil) to Oct. 2024 ($-0 Mil) but then increased from Oct. 2024 ($-0 Mil) to Oct. 2025 ($0 Mil).

The Cooper Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for The Cooper's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The Cooper Other Stockholders Equity Chart

The Cooper Annual Data
Trend Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24 Oct25
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 -0.00 0.00

The Cooper Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
COO
89GF Score
The Cooper Companies Inc COO
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

The Cooper Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of $0 Mil mean?
The Cooper (COO) has a Other Stockholders Equity of $0 Mil as of Apr. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on The Cooper and its competitors.
Is The Cooper's Other Stockholders Equity too high?
The Cooper's current Other Stockholders Equity is $0 Mil. Overall, The Cooper has a GF Score™ of 89/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does The Cooper's Other Stockholders Equity compare to SOLV and ALGN?
The Cooper's Other Stockholders Equity of $0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Medical Devices & Instruments company?
A good Other Stockholders Equity depends on the Medical Devices & Instruments industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on The Cooper and its competitors. The Cooper's current Other Stockholders Equity is $0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Cooper stock overvalued right now?
Based on GuruFocus' analysis, The Cooper (COO) is currently considered Significantly Undervalued. The stock's GF Value™ is $100.88, compared to a current price of $70.74 — trading 29.9% below its estimated fair value. The current Other Stockholders Equity is $0 Mil. The Cooper's overall GF Score™ is 89/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For The Cooper (COO), the current Other Stockholders Equity is $0 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is The Cooper (COO) Overvalued in 2026?

Based on GuruFocus' analysis, The Cooper stock appears to be undervalued. The current stock price of $70.74 is trading 29.9% below its estimated GF Value™ of $100.88. GuruFocus considers The Cooper to be Significantly Undervalued.

Key valuation signals for COO:

  • Other Stockholders Equity: $0 Mil
  • GF Value™: $100.88 vs. price of $70.74 (29.9% below fair value)
  • GF Score™: 89/100 with 3 warning signs

No single metric tells the full story. See the COO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

The Cooper Business Description

Address 6101 Bollinger Canyon Road, Suite 500, San Ramon, CA, USA, 94583
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.
89GF Score

Get the complete analysis for COO

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$70.74
Price
$100.88
GF Value